Skip to main content
    J

    Journey Medical Corp (DERM)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $3.90
    +0.20 (+5.41%)

    Market Cap: $122.24M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Journey Medical Corp (DERM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Journey Medical (DERM) has a market cap of $122.24M and an enterprise value of $125.49M. Its share count is up 12.46% from a year earlier.

    Total Valuation

    Enterprise value is 2.66% above the market cap, as debt exceeds cash.

    Market Cap$122.24M
    Enterprise Value$125.49M
    Latest price (Nov 17, 2026)$3.90

    Key Dates

    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.09% in the quarter ended Sep 30, 2026 and grew 16.91% a year over 2 years.

    Shares Outstanding28.07M
    Shares Change (YoY)+12.46%
    Shares Change (QoQ)+2.09%
    Share Count Growth (2Y CAGR)+16.91%

    Valuation Ratios

    Sales and book value multiples are 1.6x and 3.4x. Its year-end P/S ranged from 0.5x to 3.0x from 2021 to 2025.

    P/S Ratio1.6x
    Forward P/S1.7x
    P/B Ratio3.4x
    P/TBV Ratio14.2x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 43.3x EBITDA.

    EV / Sales1.8x
    EV / EBITDA43.3x

    Price Statistics

    The stock is down 50.57% over 52 weeks and trades 31.94% below its 50-day average.

    Beta (1Y)1.87
    52-Week Change-50.57%
    1-Month Change-24.56%
    3-Month Change-42.73%
    6-Month Change-36.59%
    Total Return (1Y)-50.57%
    Total Return (3Y CAGR)-0.76%
    Total Return (5Y CAGR)-15.63%
    Return vs SPY (1Y)-62.50%
    Max Drawdown (1Y)-60.04%
    Max Drawdown (3Y)-63.32%
    Sharpe Ratio (1Y)-1.02
    Correlation with SPY (1Y)0.37
    50-Day Average$5.73
    200-Day Average$6.39
    52-Week Range$3.64 to $9.55
    RSI (14 Days)31.1
    Average Volume (20 Days)214.84K

    Price chart

    Financial Position

    Current assets cover 1.48x current liabilities, and total debt is 0.79x shareholder equity.

    Current Ratio1.48x
    Quick Ratio1.34x
    Debt / Equity0.79x
    Debt / EBITDA9.83x
    Interest Coverage-0.56x

    Returns and Efficiency

    Return on invested capital is -2.78% over the last 12 months, against a 5-year average of -55.45%.

    Return on Equity (ROE)-15.83%
    Return on Assets (ROA)-4.92%
    Return on Invested Capital (ROIC)-2.78%
    Return on Capital Employed (ROCE)-4.05%
    ROE (5Y Average)-81.41%
    ROA (5Y Average)-21.76%
    ROIC (5Y Average)-55.45%
    Asset Turnover0.74x
    Inventory Turnover2.97x
    Receivables Turnover1.66x
    Cash Conversion Cycle208 days

    Scores

    DERM has an Altman Z-Score of 0.44, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score0.44
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $69.52M over the last 12 months is up 17.03% from the 12 months before.

    Revenue$69.52M
    Revenue Growth (YoY)+17.03%
    Gross Profit$45.83M
    Operating Income-$2.01M
    Pretax Income-$5.09M
    Net Income-$5.10M
    EBITDA$2.60M
    EBIT-$2.04M
    Reported EPS (TTM)-$0.18

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 31.05% of the $103.85M in total assets.

    Cash and Equivalents$22.32M
    Total Debt$25.58M
    Net Debt$3.25M
    Net Debt Per Share$0.12
    Working Capital$25.74M
    Shareholder Equity$32.25M
    Book Value Per Share$1.15
    Tangible Book Value$7.71M
    Tangible Book Per Share$0.27
    Total Assets$103.85M
    Total Liabilities$71.60M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$8.55M
    FCF Per Share-$0.38
    Depreciation and Amortization$4.64M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2.89%, against a 5-year average of -26.56%.

    Gross Margin65.93%
    Operating Margin-2.89%
    Pretax Margin-7.32%
    Net Margin-7.34%
    EBITDA Margin3.74%
    EBIT Margin-2.93%
    Gross Margin (5Y Average)61.49%
    Operating Margin (5Y Average)-26.56%
    Net Margin (5Y Average)-31.88%

    Growth

    Revenue fell 5.66% a year over 3 years.

    Revenue Growth (3Y CAGR)-5.66%
    Revenue Growth (5Y CAGR)+6.79%
    Book Value Per Share Growth (2Y CAGR)+11.11%
    Tangible Book Per Share Growth (2Y CAGR)+629.21%

    Revenue and profit by year

    Dividends and Yields

    DERM does not pay a dividend.

    Buyback Yield-5.15%
    Shareholder Yield-5.15%

    Peer Position

    Against 7 similar companies, DERM has the 4th highest P/S.

    P/S Ratio1.6x vs 1.4x median
    ROIC-2.78% vs -38.86% median
    Revenue Growth (Trailing 4 Quarters, YoY)+17.03% vs +9.42% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 27.60% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+27.60%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DERM

    What is DERM's market cap?

    Journey Medical has a market cap of $122.24M. Its enterprise value, which adds debt and subtracts cash, is $125.49M.

    How many shares of DERM are outstanding?

    Journey Medical has 28.07M shares outstanding. The count is up 12.46% from a year earlier.

    Does DERM pay a dividend?

    No. Journey Medical does not pay a dividend.

    How much debt does DERM have?

    Journey Medical has $25.58M of total debt and $22.32M of cash and equivalents, a net debt position of $3.25M.